CE Courses
CE for MLS & MLT
CE for Phlebotomists
CE for Histologists
HR Courses
Intro to the Medical Lab
Video CE Courses
All Available Courses
Exam Simulators
Exam Simulator for MLS & MLT
NSH + LabCE Histology Exam Simulator
Phlebotomy Exam Simulator
Molecular Exam Simulator
Case Simulators
RBC Morphology Simulator
White Blood Cell Differential Case Simulator
Advanced WBC Differential Case Simulator
Urinalysis Case Simulator
Body Fluid Case Simulator
Bacteriology Case Simulator
Blood Culture Gram Stain Case Simulator
LabCE Quiz Game
Contact & Support
Log In
Log In
What conclusions can be made regarding the clinical use of biomarkers to identify and diagnose PE?
This version of the course is no longer available.
Need multiple seats for your university or lab?
Get a quote
The page below is a sample from the LabCE course
Detection and Management of Preeclampsia: Current Laboratory Testing and Emerging Biomarkers (retired 4/6/2020)
. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.
Learn more about Detection and Management of Preeclampsia: Current Laboratory Testing and Emerging Biomarkers (retired 4/6/2020) (online CE course)
What conclusions can be made regarding the clinical use of biomarkers to identify and diagnose PE?
More than one answer
is correct. Please select all correct answers
None of the biomarkers appear to have sufficiently high positive predictive value when used alone.
More studies are needed to confirm the clinical use of a combination of biomarkers to specifically predict PE.
There is a lack of validation studies and lack of agreement on cut-off points to determine abnormal levels for the biomarkers.
X
×